On June 29, 2021 Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA) technology, reported that CEO David Giljohann will present a company update as well as participate in a series of 1×1 meetings at the Ladenburg Thalmann 2021 Healthcare Conference occurring July 13-14, 2021 (Press release, Exicure, JUN 29, 2021, View Source [SID1234584479]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Date: July 13, 2021
Presentation Time: 1:00-1:25 PM in Track One
Location: The panel discussion will be webcast (available here)

Replays of the presentation will be available on Exicure’s website for 30 days following the presentation.